CEBPB Antikörper (AA 1-271)

Produktnummer ABIN532929

Produktdetails anti-CEBPB Antikörper

Target: CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))

Bindungsspezifität: AA 1-271

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CEBPB Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Verwendungszweck: Mouse monoclonal antibody raised against partial recombinant CEBPB.

Kreuzreaktivität: Human, Maus

Immunogen: Recombinant protein corresponding to amino acids 1-271 of human CEBPB.

Klon: 47A1

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Western Blot (1:500-1:2000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS, pH 7.4 (10 % glycerol, 0.02 % sodium azide).

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Store at 2°C to 8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-CEBPB Antikörper (ABIN532929)

Su, Chou, Chang, Lee, Chen, Huang, Lee, Lee: "Differential activation of a C/EBP beta isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene." in: The Journal of biological chemistry, Vol. 278, Issue 51, pp. 51150-8, (2003) (PubMed).

Parkin, Baer, Copeland, Schwartz, Johnson: "Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP)." in: The Journal of biological chemistry, Vol. 277, Issue 26, pp. 23563-72, (2002) (PubMed).

Details zu CEBPB

Target: CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))

Andere Bezeichnung: CEBPB (CEBPB Produkte)

Synonyme: C/EBPbeta antikoerper, c/ebp-beta antikoerper, crp2 antikoerper, il6dbp antikoerper, lap antikoerper, nf-il6 antikoerper, tcf5 antikoerper, xC/EBPbeta antikoerper, cebpbb antikoerper, cb380 antikoerper, c/ebpb antikoerper, fe11e05 antikoerper, wu:fe11e05 antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, C/EBP-beta antikoerper, CRP2 antikoerper, IL6DBP antikoerper, LAP antikoerper, NF-IL6 antikoerper, TCF5 antikoerper, IL-6DBP antikoerper, LIP antikoerper, NF-M antikoerper, Nfil6 antikoerper, Il6dbp antikoerper, CCAAT/enhancer binding protein beta antikoerper, CCAAT/enhancer binding protein beta L homeolog antikoerper, CCAAT/enhancer binding protein (C/EBP), beta antikoerper, CCAAT/enhancer-binding protein beta antikoerper, cebpb antikoerper, cebpb.L antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, Cebpb antikoerper

Gen-ID: 1051

NCBI Accession: NM_005194

Pathways: Interferon-gamma Pathway, Autophagie, Brown Fat Cell Differentiation